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C ol~lponent~ of the cutaneous ,~ e rvol's system inte ract WIth multIple types of cells U1 thc skin to mediate actions important in skin inflammation and wound healing [1-5]. Ovcr 100 years ago it was observed tha t antidromic stimulatio n of thc scnso ry nerves 
emanating from dorsa l root ganglia produced vasodilation and 
apparcnt local inflammation of the skin (for review see [6]). This 
observation, repeated many times since, led to the understa nding 
that the cutaneous sensory nervou s system (CSNS) not only relays 
sensory information from the skin to the central nervous system 
(CNS), but also plays an effector role in the skin' s inflammatory 
.responsc [7-9]. 
Scnsory neurons express at least 17 different neuropeptides [6] . 
Severa l of these, substance P (SP) [6,10,11], calcitonin gene-rela ted 
peptide (CGRP) [12-14], substancc K (SK) [10 , 15,16], and vaso-
active intesti nal polypeptide fl7-20] , havc activities or cellular 
localizations that suggest invol vem ent "in tissue repair. SP is the 
prototype of ne uropeptidcs releascd from sensory C -fibers in the 
skin [21] . The activities ofSP require not only secretion but also the 
expression of the SP rcceptor (SPIt) on local target cell s and 
exp ression of tissue proteascs that degrade neuropeptides, such as 
ne ut ral endopeptidase (NEP). 
Another important facet of ncrvous system- cutaneous in te ra c-
tions are ne urotrophic growth factors th;lt mediate cutaneous 
reinnervatio n , e.g., ncrvc growth facto l' (NGF) [22,23 ], brain-
derived nerve growth fa ctor [24,25], neuro trophin-3 [26], and 
human neurotrophin-5 (27). NGF is produced by the ncura l 
Schwann cell s and by the regcnerating epidermis itself [28,29]. 
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rcceptor. 
BIOLOGIC ACT IVIT IES OF SP AND SPR 
SP Biochemistry and Tissue Distribution SP, an J 1-amino 
acid peptide that is a membcr of the tachykin in hunily of neuropep-
tides, is present in m3ny areas of the nervous system bu t is one of 
a few neuropeptides restricted to cell s of neural crcst origin [30,31] . 
It is located in nerve endings throughout thc body, but especially in 
areas of immunologic importance such as the skin , gastrointestinal 
tract, resp iratory tract, and eye [31]. In the peripheral nervous 
system, SP occu rs in a subpopulation of primary afferent neurons 
including A-o pain fibers and C-fibers, which tran smit impulscs 
initiatcd by noxious stimuli , and in nervc plcxuses of the gastroin-
testinal tract. The role of SP as a ne urotransmi ttcr is suppo rted by 
its presence in synaptosoma l fra ctions and large granular vesicles in 
nerve endings of synapses within dorsaJ ho rn cell s [32]. 
SP is synthesized in the dorsal root ganglia, from which it 
migratcs centrally to the dorsa l ho m of the spinal cord and 
peripherally to nerve terminals of sensory ncuron s [21] . A single 
gene has been identified that can be differentially proccssed into 
two diffe ren t SP precursor mRNAs, c.l'- and {:l-preprotachykinin 
[33,34]. Thc first contains the seq uence of 5P only whereas the 
second conta ins the sequences of SP as well as a second tachykinin-
peptide, SK [33,35]. SP and 5K share a commo n spectrum of 
biologic activitics [10 ,36,37] , but levels of the t'wo prccursor 
mJ.~NAs va ry between tissucs [33,38] , the C NS producing more 
a -preprotachykinin and the peripheral nervou s system (PNS) pro-
ducing more {:l-preprotachykin in [34]. SP is degraded by a specific 
thiorphan-sensitive enkephalinasc, CD10, also known as NEP 
[39 -41]. 
SP Receptor Biochemistry The amino acid sequence of the 
human and rat SPR nc uro kinin (NK,) . ha s becn deduccd fro 111 
m olecular cloning data [42-44]. The receptor protein is composed 
of 407 residues with seven putative m embrane-spanning domains 
and shares scquence hom ology with the SI( receptor (NK2 ) in its 
transmembrane regions and in its first and second cytoplasmic loops 
[45,46]. The SPIt mRNA is ex pressed by ne uro ns and g lia in the 
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Table I. II/. Vitl'O Effects of the Neuropeptide Substance P on the Inunune System 
Effect Specifics 
Cellular proliferation 
Ig production 
• Enhances T-ceJ1 proliferation (much greater in Peyer's patches than in spleen) [98J 
• Increase IgA and IgM [102J 
• Increase heavy-chain mRNA [1 021 
Cytokine production/secretion • Enhances IL-2 synthesis and secretion by peripheral blood monocyte ceJ1 s and .HUT 78 cells [lOS] 
• Enhances IL-2 receptor expression on Jurkat-SP-R. cells [104] 
• Enhances IL-1, IL-6, TN FLY, and interferon 'Y production by monocytes It 03] 
• Enhances expression and secretion of IL-I ex, IL-1ra, and granulocyte/macrophage colony-stimulating f.~ctor 
by kcratinocytcs [57] 
• Enhances TNFcr secretion by ,m,st ce lls [561 
Phagocytosis 
Mediator release 
• Enhances macrophage and polymorphonuclear-leukocyte activity [1 08,185,186] 
• Enhances histamine, prostaglandin, and leukotricne release from mast ce lls [106] 
Cell homing. chemotaxis • Enhances human monocyte chemoraxjs [186,187] 
• Alters CD2 and CD45 levels on Jurkat-SP-R cells [104,188 \ 
CNS, neurons of the myenteric plexus, smooth muscle cells , acinar 
cells, endothelial cells, fibroblasts, various types of circulating 
immune cells , and skin 142,47-50] . Sites of expression agree well 
with earlier autoradiographic localizations [51-53]. SP, with a kD 
of 0.5- 1.0 nM , is the most potent ligand for the NK, receptor [54] . 
Activation of the NK, receptor results in inos.itol phospholipid 
hydrolysis and the transient appearance of inositol 1,4,5 triphos-
phate, the release of Cn -I- -I- from internal stores, and an oscillatory 
chloride current (55]. We have identified SPR in the skin on 
keratinocytes and mast cells [56,57], whereas other recent studies 
have demonstrated SPR o n endothelial cells [58,591. 
Actions of SP In the CNS, SP is thought to act in the cortex, 
hypotlnlamus, and lower brainstem [60-67] . SP in the PNS has 
numerous actions including contractio n of the smooth muscle 
layers in the gastrointestinal tract [68,69]; production of edema and 
broncboconstriction in th e respiratory tract [70-72] ; enhan cement 
of nasal secretion [70,73]; stimulation of trach eal, epith elial, and 
glandular secretion of glycoprotein-rich fluid [74]; calcium-depen-
dent secretion by the parotid and submandibul ar glands [75]; and 
modulation of both exocrine and endocrine pan cl"eatic function 
[76-79]. Blood and tissue concen trations [80-82] of SP suggest 
that the peptide is available locall y at fu nctionall y relevant concen-
trations. The peripheral actions of SP possibly involved in cutaneous 
neuroillfl ammation fall into three main categories: 1) vasodi lation 
and increased vascular penneabiJity, 2) local inflammation and effects 
on the immune system, and 3) promotion of cellular proliferation. 
Vasodilation and Increased Vascular Permeability In-
creased blood fl ow and vascular permeability arc effects well 
established in several animal species and humans [83- 85]. Vasodi-
lation is due to direc t actions of SP on vascu lar smooth muscle 
[85,86] and enhanced production of nitric oxide by the endothe-
lium [87]. SP is also the mediator of an tidromic vasodi lation, as 
shown by its presence in unmyelinated primary sensory fib ers in the 
skin [86,88], its release fi'om peripheral endings of sensory neurons 
during antidromic stimulation [89,90], and its vasod il atory effects 
after venous illfusioll [91J. In addition, SP C;1Il initiate micl'Ov<}scuJar' 
pemleability and protein extavasation after tissue injury [31,91,92]. 
Intradermal injec tion of SP in hum ans produces a wheal caused by 
increased vascular permeability followed by a flare reaction caused 
by reflex neurogenic vasodilation [93-95]. The reflex nature of the 
fla re is demonstrated by its inhibi tio n by local anesthe tics ; th e wheal 
response remains unafFected [96,97]. 
Local Inflammation and Specific Effects on the Immune 
System SP has been shown to have stimulatory efFects on the 
immune systelll both ill lIilro and ill lIil'O [98-100] (Table I) . 
JrutiaIJy, SP was found in hig h concentrations in inflamed tissues 
such as the joints in experimental arthritis in the rat [101]. Later, 
injectious of SP into normal joints produced inflammation that 
mimicked adjuvant-induced arthritis [101] . 
NanoLllolar concentrations of SP enhance proliferation of both 
human and murine peripheral-blood T lymphocytes [98,99]. CH]-
thymidine and CI-I]-Ieucine uptake by human T lymphocytes is 
stimulated up to 60-70%, by both SP and a C-terminal fragment of 
SP, SP4 _ 11 ' both in the presence and absence of oth er mitogens 
[98] . SP also increases, by up to 300'X" the s~1thesis of immuno-
g lobu lins fi-om mixed lymphocyte cultures fi"olll the spleen, lymph 
nodes, and Peyer's patches, the major effect being on IgA [99]. 
More recently, Pascual ci nl, using an IgM- and IgA-producing 
B-Iymphoma cenline, showed that SP can syn ergize with lipopoly-
saccharide to increase the production of these two immunog lobu-
lins [102]. Conti.nuous infusion of SP lIin miniosmotic pumps 
stimu lated prolife ra tion of lymphocytes isolated fi'om tile spleen 
and Peyer"s patches in mice, and immunoglobulin s~lthesis , pa r­
ti cularly IgA, was also increased [100]. SP has effects on cytoki.lle 
regulation including enhanced production of cytokines such as 
interl eukin 1 (IL-l), IL-6, tumor necrosis factor a (TNFa ) , and 
interferon- y by monocytes [103], in crease in IL-2 receptors i.n a 
Jurkat T -cell line expressing a transfected SPR cDNA [104], and 
augmen ted IL-2 synthesis in per'iph eral blood monocyte cells and 
HUT 78 cells [105J . 
SP can also modulate acute hypersensiti vity responses. At micro-
molar concentrations SP evokes the release of histamine from rat 
serosal or connective-tissue-type mast cells [106]. UnHke other 
basi c peptides, which stim ul ate mast cells nonspecifi cally, SP action 
is cell specific and includes stimulation of the generation of 
unstored mediators such as leukotrienes [107,108]. The mast cell 
respon ses e licited by SP were distinguished from those dependent 
on IgE by the apparent lack of a requirement for extracellular 
calciulll [106] . 
We have recently demonstrated [56] that mast cell TNFa 
mRNA is se lectively up-regulated by SP in a concentratio n-
dependent manner. SP increased secreted TNFa from both cloned 
murine CFTL 12 mast cells and fi'esbly isolated peritoneal lll ast 
cells. T he addition of SP to cultured mLU;ne and normal human 
foreskin keratinocytes resulted in concentration-dependent in-
creases in mRNA for IL-l a, IL-1 {3 , and IL-1ra that were m aximal 
after 3 h of exposure ([57], unpublish ed obser'va tions), but no 
efFects on keratinocyte TN Fa or IL-8 were found. It is interes tin g 
that SP, _~, but not the C -terminal fi:agments S1'4_'1 or SP7_1 1' are 
capable of inducing production of some cytokines by keratinocytes. 
More recently, we observed that SP can also specifically activate 
normal hum an rnicrovascular endoth elial cells to produce the 
ne utrophil activating cytokine IL-8.1l 
Promotion of Cell Proliferation N europeptides, especially 
S1', ha ve also been implicated in the m o dulation of inflammation 
and wound healing by the ability to promote proliferation of 
various types of target ce lls. SP has been shown to act tllro ugh the 
" Kramp J , Brown J, Cook P, Russell 13 , Lawley T , Armstrong C, Ansel 
J: Ncuropeptidc induction of human microvascular endothelial ce ll in ter-
lcukin 8 (abstr). J IIIl lcst Denllmol 104:586, 1995. 
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SPR to stimulate proliferation of cultured keratinocytes [11]. 
Additionally, SP and SK can stimulate proUferation of arterial 
smooth muscle cells and therefore may assist in angiogenesis during 
healing [1.0 ,16,109]; SP has also been shown to stimulate neovas-
culari zatio ll ill lIillo [110]. SP and SK stimul ate the proliferation of 
both human skin fibroblasts [10] and cultured endoth elial celJs 
[110], suggesting that SP released from the skin in association with 
tissue injury may not only enhance vasodilation and the inA amma-
tory response, but may stimulate proliferation of cutaneous epi the-
lial, vascula r, and connective tisslle. 
ROLE OF NEP IN R EGULATING 
N EUROPEPTIDE ACTIVITY 
NEP Biochemistry and Tissue Distribution The biologic 
actions of neurotransmitters sllch as acetylcholine are terminated by 
enzymatic degradation. by re-uptake into nerve endings, and/or by 
diffusion away from the target cell [111 . 11 2]. Accumulating evi-
dence suggests that neuropeptides are degraded and inactivated by 
cell surface peptidases [113]. The best-studied cell surface pepti-
dase, ne utral endopeptidase (EC 3.4.24.11. N EP), also known as 
enkeph alinase, common acute lymphoblastic le ukemia antigen, o r 
CD 10, is the major tachykinin-degrading enzyme. N E P was 
discovered in the brush borde r of the kidney in 1968 as an enzyme 
that hydro lyzed the {3 chain of insulin [11 4] but was no t obtained in 
pure form until 1974 [115 ,116] and has also been isolated from 
other tissues. Interest in NEP was rekindled in 1978 when NEP was 
shown to degrade enkephalins in the brain [117] . NEP degrades 
tachykinins, opio id peptides, GRP-I0, somatostatin-14 , neuroten-
sin , cholecystokinin (CCK), gastrin. vasoactive intestinal polypep-
tide, CGRP, and others [118-1 20]. Altho ugh tachykinins and 
enkephalins are the best substrates , the proximity of peptidergic 
neurons to cel.l s that express N EP also determines whether a 
neuropeptide can be a relevant physiologic substrate for NEP. The 
consensus is that N EP in the nervous system is found in ne urons 
rather than glial cells. In the do rsal horn of the spinal cord and the 
trigemin al nucle us, staining for NEP, SP, and enkeph alin s is 
supe rimposa bl e . 
T he search fo r a physiologic role of NEP has been facilitated by 
. use of the specifi c inhibi to rs phosphoramidon and thiorphan. T he 
release of both enkephalins and Sl) from brain slices ill "ilm is 
enhanced in the presence of NEP inhibitors [1 21 .1 22], and these 
inhibi to rs relieve pain [122-124], which is consisten t with their 
e ll:ccts on endogenous opioid peptide release and stability. [n the 
airways, inhibitors of N EP potentiate effects of SP o n tracheal 
secretion [74], bronchomotor tone [1 25], and co ugh [126]. In 
addition, inhibi tion o f NEP has been shown to potentiate tracheal 
neurogenic inAammation [1 27] . The mechanism by which NEP 
m odulates the effects of neuropeptides is w idespread and phyloge-
netica lly ancient. For example, phosphoramidon stimulates the 
growth of small-cell lung ca rcinoma cell s by preventing the 
inactivation of endogenous GRP (an autocrine growth factor) by 
NEP [128] . An NEP-like enzyme is also found in hemocytes of the 
mollusc M),l illIs edlltis, and inhibition of NEP activity decreases by 
five orders of magnitude the amount of Met-enkephalin required to 
activate these cell s [1 29]. 
Although regulation of N EP activi ty and expression has received 
little attention, changes in its activity have pro fo und e ffec ts 011 the 
cellula.r response to neuropeptides. NE P activity in the trachea is 
reduced by up to 50'Yu by infection [130] , and NEP is down-
regulated by intestinal inAaml11ation ; as a result, the degradation of 
SP by inAamed tissue is markedly red uced [131] . T he ability o f 
glucocorticoids to stimulate expression of N EP by transformed 
tracheal epithelial cells [13 2] and to down-regulate SPR [1 33] may 
partly expl ain their anti-inflammatory pro perti es . 
CUTAN EO US N GF 
NGF Biochemistry and Tissue Distribution NGF, a 11 8 -
amino acid , - 130-kD protein isolated more th an 40 years ago as all 
agent stimu.latin g growth ,md ne urite development in embryonic 
sensory cells [1 34], is the best-characterized m ember of the neuro-
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tro phin family [13 5] . NGF is composed of three subunits, IX , {3, and 
-y, but bio logic activity appears to reside in the 26-kD {3 subwlit 
(2.5S N GF) [136] . 
In th e mature animal, N GF is expressed in the CNS and 
peripheral tissues [137,13 8] including keratinocytes of mouse and 
human epidermis [28,29,139]. N GF mRNA in keratinocytes is 
increased by ultraviolet radi ation and phorbol esters, and reduced 
by hydrocortisone [28,29] . Anti-NGF monoclonal antibody staiued 
only basal keratinocytes obtained fro m growing colonies; cells from 
conAuent cultures and fully differentiated cells showed no evidence 
of NGF staining [29] , suggesting a role for NGF productio n by the 
regenerative epidermis in wound healing. 
NGF Receptor One N GF recepto r (NGFR) protein is a more 
NGF- R 
abundant low-molecular-we ight prote in of - 75 kD, p75 , 
that bi.nds NGF with low affinity. and the second is a - 140-kD 
protein that binds NGF with high affinity [1 40]. Both are required 
for high-affinity binding and a normal ceIJul ar response. The 
transmembrane protein p75 NGF- R appears to serve as a common 
subunit fo r different neurotrophin receptors, whereas the specificity 
of the receptor is conferred by the second subunit [141]. The 
higher-molecular-weight subunit is now known to be the proto-
oncogene. Irk, a m ember of the tyrosine kinase receptor family 
[142, 143] . 
General Biologic Actions ofNGF NG F has been shown to be 
both neurotrophic and ne urotactic in the C N S. The outgrowth of 
processes fi·om ga nglio n ne uro ns is dependent on NGF [1 44], and 
N GF is also crucial for neu.ronal survival and function. Exposure of 
fetal rats to antibodies to NGF causes the ablation of an entire 
population of sensory neurons including those containing SF 
[145,146]. NGF is taken up by sensory ne urollS and transported in 
retrograde fashion to the cell body [147]. Deprivation of NGF 
results in reduced levels of SP in dorsal root gangl.ia [148] . 
Effects of Wounding on Skin Innervation Innervation of 
skin is altered by wounding [149-153]. In rat and guinea pig skin, 
SP-containing nerve fibers disappea r from wounded skin within 
1-2 d [152,153] and regenen'ting fibers begin to return after 3 d, 
increasing gradually for - 2 w eeks after wounding and resu.l ting in 
hyperinnervatio n . The new fibers ex hibit extensive sprouting and 
form an ullusually dense network just beneath the regrowing 
epidermis and then decrease ill number over several weeks, folJow-
ing the course of healing and sugges ting a fu nctional link between 
regeneratio n of the CSNS and the integrity of the skin. 
Role of NGF in Reinnervation of Wounded Skin After 
injury to a cutaneous nerve, denervated skin is reinnervated by two 
mechanisms, axonal regeneration (i .e. , the regrowth of injured 
axons) and collateral reinnervation (i .e., the sprouting of undam-
aged axons in adjacent tissues in to the denervated area) [154] . T he 
latter has been shown to be completely dependent on NGF, 
because reinn ervation does not occur after depletion ofNGF [1 55]. 
Furthermore. collate ral reinnervatio n is blocked by passive or 
active immuniza tion against NGF [23,156] . Diamond el at went 011 
to show that intradermal injectio n of N G F produced collateral 
sprouting in no rma.l, fully innervated skin, increased the rate of 
sprouting in denervated skin, and restored the rate of sprouting in 
anti-NGF-treated denervated skin [23]. Finally, there appears to be 
an increase in synthesis ofNGF within den ervated tissue [23,157). 
As m entioned above , keratinocytes express and synthesize NGF 
and may be the source o f the endogenous growth factor utilized in 
spro utin g . This is especially likely beca use a) reinnervating nerves 
enter the wound frolll the edge along with the epithelial tongue 
1152] and b) there is an unusu ally dense arborization of nerves just 
beneath the rapidly growing keratinocyte layer, which contains 
kera tinocytes known to express the highes t level ofNGF [29]. It is 
possible. however, that NGF from Schwann cells , fibrobl asts, and 
smooth muscle cells may also be involved . 
NG F may also playa significant role in axonal regeneration after 
injury [1 58] . TIllS hypothesis is based upon several observations: a) 
dorsal root ganglia have high-affinity NGF receptors [140]; b) 
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Schwann cells make NGF [159]; c) NGF and NGFR levels increase 
in degenerating nerve pathways and then become down-regulated 
w hen regenerating axons arrive r160]; and d) w hen peripheral 
nerves are cut and begin to degenerate, thei r Schwann cells start to 
express low-afrinity NGFR and this expression disappears when the 
regeneratin g axon arrives [158,160]. It is thought that NGF is 
bound to the NGFR on Schwann cells and is then transferred to 
high-affini ty NGFR OJl the regenerating aXOl1s because of the 
differences in bindillg affin.ities of the two types of receptor. T he 
tole ofNGF in axona l regeneration has been questioned recently by 
evidence that nerve regeneration is unalfected by treatment with 
anti-NGF antibodies [161]. 
Proinfiammatory and Proliferative Actions of NGF Para-
crine actions ofNGF may also contribute to the maintainance of the 
integrity of skin. NGF causes proliferation and release of histamine 
from mast cells [162], promotes diflerentiation of specifi c granulo-
cytes, en hances T-Iymphocyte-dependent an tibody synthesis , and 
induces growth and d ilferentiation of human B lymphocytes 
[163,164]. Furthermore, NGF may m odula te melanocyte gene 
expression, is chemotactic for melanocytes, and can enhance mela-
nocyte dendricity [139] . 
ROLE OF THE NEUROLOGIC SYSTEM IN 
WOUND HEALING 
Effects of Denervation on Wound Repair It is also an o ld 
observation that clu:onic wounds and ulcers occur in skin w ith 
absent or dysfunctional innervatio n , an event often attributed to 
pressure, ischemia, infection, o r incidental trauma related to a lack 
of sensation. Once such wounds were formed, failure to hea l was 
attributed to difficulty with hygiene, protection of the wound from 
additional trauma , worsening of the underlying disease, poor 
nutrition, and susceptibility to infection. As early as 1927 it was 
noted that damage to the PNS is capable of alte ring growth and 
repai r of skill , leading ultimately to ulceratio.n and necrosis of the 
affected area [165]. Such o bservations led to the hypothesis that 
cutaneous innervation provides "trophic" support to skin integrity. 
interest in this phenomenon has fo cused primarily o n the role of 
sensory nerves, because it was noted that the Rare response, a reRex 
of the CSNS [166,167], is absent in dene rvated skin that develops 
chronic wounds. Additiona l information has subsequently impli-
cated the CSNS as a major contributor to skin integrity. For 
example, diseases and injuries th at produce CSNS deficits (e.g., 
diabetes [168] , herpes zoster [169], and spinal cord injmy 
[170,171]) are often characterized by poor wound healin g. 
Denervation of rabbit skin by cutting of the nerves impairs the 
healing of incisiona l wounds [172J. Scars in denervated skin 
showed decreased tensile strength, hydroxyproline con ten t, and 
protein composition compared to those in control skin. N ear tota l 
sensory denervation can also be accompli shed by treatment with 
high doses of capsaicin [173]. Kjartansson e/ fl l studied the effects of 
capsaicin-induced sensory denervation on the survival of tissue in 
experimen tal critical skin Raps [17 4]. Ten days after surgery, only 
32% as much tissue remain ed in flaps of denervated skin as 
compared to flap s of innervated skin. Severe corneal les ions with 
opacity , edem a, and ulceration can be produced in neonatal mice 
and rats by ab.lation of sensory neurons with capsaicin [175] . Simi.lar 
results can be obtained by cutting the trigeminal nerve [176]. In a 
related experiment, depletion of neuropeptides in rabbit corneas by 
topical or retrobulbar inj ection of capsaicin caused a delay in 
corneal wound hea ling [1 77]. Such treatmen ts reduce the migration 
rate of epithelial ce ll s surrounding an n-heptanol-induced epithelial 
wound . T hese findings support the hypoth esis that the trophic 
elfects of sensory nerves on corneal or epidermal epitheliul11 are 
mediated by neuropep6des in tlle sensory nerve endings. 
Changes in Tissue Neuropeptide Levels After Wounding 
T he few studies th at have been conducted regarding ne uropeptide 
levels during wound healing are difficult to compaI:e due to vastly 
differing expel;mental models and neuropeptides of interest. Jon-
sson et fll showed an immediate increase in SP immunoreactivity in 
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dog paw lymph after scalding injury, indicating release ofSP during 
wounding [178]. Gri:inblad et fli observed many more SP and CGRP 
nerve fibers in healing rabbit m edial collateral ligaments as com-
pared to normal ligaments, suggesting involvement of dlese nerves 
in healing [179). Senapati e/ fl l, however, observed significant 
depletion ofSP, CGRP, and somatostatin in rat skin [180] within 1 
d of wOllnding that persisted for 14 d, consistent wiili release of 
neuropeptides at the wound site but also possibly explained by 
decreased synthesis and transport to the nerve terminals. These 
data , w hich support the ideas of an increase in neuropeptidergic 
tone at the wound site, are further substantiated by studies in which 
neuropeptide replacem ent enhanced wound repair. In a pl'eliminary 
study, Spevak e/ al foulld that wounds in rat skin healed faste r when 
treated with SP [1.81]. English e/ fll demonstrated a tTophic action of 
the CSNS o u wound healing by sh owing that inclusion of touch 
domes in skin grafts enhanced the return of neural function in the 
graft and, most importantly, the qua lity and survivability of the 
graft [182,183]. (Touch domes are specialized areas of skin that are 
rich.ly innervated and are known to provide tropic or trophic factors 
for regenerating nerves [I 84J). 
CONCLUSIONS 
There is increasing evidence that the ne rvous system ca n modulate 
tissue inflammatory, pro liferative, and reparative processes. T he 
rol e of the CSNS and neuropeptides such as SP in inflammation and 
tissue repair is determined not only by the synthesis and secretion of 
neuropeptides such as SP, but also by availability of and interaction 
with its receptor on target cells and by the rate ofSP degradation by 
tissue peptidases sllch as NEP. Furthermore, the rate at which 
re inn ervation of wounds occurs may have dramatic effects on the 
time course and quality of tissue repair, thus pointing toward a 
crucial ro le for neurotropic and neurotrophic factors like NGF. 
Our current understanding of the different components of this 
complex system suggests that defects in skin i.ntegrity and wound 
healing in patients with neurologic sensory defi cits may be caused 
by abnormalities in growth and function of the CSNS. In view of 
the scale of the clinical problem represented by chronic wounds, 
increasing our kllOwlcdge of the interaction between the CSNS and 
wound hea ling has the potential for making a significant impa ct on 
therapy. 
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